Загрузка страницы

Must See: The first trial with Artificial Pancreas system in a diabetes camp - Voice over in English

The Diabetes wiREless Artificial pancreas consortiuM (DREAM) recently evaluated the MD-Logic Artificial Pancreas (MDLAP) system in an innovative trial project taken place in Israel, Slovenia and Germany. The aim of the trial was to provide a real solution to patients with diabetes, using the MDLAP in a diabetes camp outside the confines of the hospital. This is a significant landmark in research: this is to the best of our knowledge the first time in the world that such a trial project has been taken outside the hospital, illustrating a "normal" life for youngsters with diabetes, while using an automatic insulin delivery system during the night.

The MD Logic system which was developed at Schneider Children's represents the "artificial pancreas" technological solution comprising of an off-the-shelf subcutaneous glucose sensor that monitors the glucose level and an insulin pump. The sensor and pump are connected to a computer that programs the information and stipulates the amount of insulin that should be released to the body in order to maintain blood glucose balance. This innovation "closes the loop" between the sensor and the pump and relieves the patients with diabetes from the daily burden of dealing with their diabetes and has the potential to significantly improve the quality of life of patients with diabetes.
The artificial pancreas trial outside the hospital was conducted as a prospective cross-over study within the framework of the 3-day DREAM Camp for children with diabetes.

The movie shows the first trial conducted at the Kibbutz Maale Hachamisha Hotel, Israel. The study was consisted of 18 children and youth between the ages of 12-15 years stayed. Nine children were connected to the artificial pancreas system on the first night of the camp and eight children were connected on the second night. Monitoring the night-time glucose levels is extremely important since most cases of severe hypoglycemia occur during the night and blood glucose levels are not within the desired range in many of the patients while they are asleep. The team of engineers and medical staff stayed in the control room set up at the hotel on both nights, from where they were able to remotely supervise the trial and monitor the glucose levels of the children. Within the framework of the camp, social activities with counselors and the team of the Institute for Endocrinology and Diabetes took place: the children enjoyed the interaction between themselves, swimming in the pool, sports, watching movies and other fun activities.

Видео Must See: The first trial with Artificial Pancreas system in a diabetes camp - Voice over in English канала מרכז שניידר לרפואת ילדים בישראל
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
8 мая 2012 г. 18:00:31
00:07:07
Яндекс.Метрика